By Maryam Abubakar Tukur
The Kano State Drugs and Medical Consumables Supply Agency (DMCSA) has successfully conducted its 10th Quarterly Review Meeting, marking a significant milestone in its ongoing commitment to strengthening the state’s health supply chain system and ensuring uninterrupted access to life-saving drugs and medical consumables.
The review meeting, chaired by Honorable Commissioner of Health Dr. Abubakar Labaran Yusuf and held on Tuesday at DMCSA, highlighted remarkable achievements recorded within the reporting period, reflecting the Agency’s strategic reforms, prudent financial management, and unwavering dedication to service delivery.
The notable achievements recorded include a clearance of inherited debts of over N1.178b, a substantial increase in fund value, as well as an increase in stock availability.
Speaking at the meeting, the Commissioner of Health Dr. Abubakar Labaran Yusuf commended the leadership of DMCSA for recording such significant advancements in the health supply chain maturity assessment, reflecting continuous improvement in governance, data management, logistics systems, and workforce capacity."
"This progress positions DMCSA as a model for supply chain excellence within the region."
Dr. Yusuf assured the residents of Kano that the DMCSA remains focused on consolidating its successes by expanding access to quality medicines, enhancing digital supply chain systems, strengthening transparency and accountability mechanisms, as well as building resilient and responsive healthcare logistics.
He further thanked Kano State Government under the leadership of Governor Abba Kabir Yusuf for utmost support and cooperation to the Ministry of Health, and the development partners for their numerous health interventions in the state.
Delivering a welcome address earlier, the Director General of DMCSA Pharm. Gali Sule noted that "The Agency recorded a notable increase in fund value to the tune of N628,774,541, thereby reinforcing its operational capacity and enabling improved procurement, distribution, and overall supply chain efficiency."
He also added that the stock availability across health facilities rose impressively to 93.8%, demonstrating enhanced inventory management systems and effective distribution mechanisms. "This milestone," according to Pharm. Sule, "ensures that drugs are consistently available to meet the healthcare needs of our teeming population.
"In a landmark financial achievement, the Agency successfully cleared inherited liabilities amounting to ₦1.178 billion, signaling strong fiscal discipline, accountability, and a renewed foundation for sustainable growth."
The Director General then reaffirmed the Agency’s commitment to sustaining these gains while pursuing further innovations aimed at strengthening the health system. He emphasized that the achievements recorded are a result of collective effort, stakeholder collaboration, and strong government support.
Pharm. Sule expresses appreciation to all partners, stakeholders, and staff whose dedication made these accomplishments possible and reiterates its commitment to delivering a more efficient, reliable, and sustainable health supply chain system for the people.
During the meeting, presentations were made to assess the operational activities at DMCSA and other relevant health parastatals and programs.
At the end of the meeting, an Award of Leadership in Supply Chain was presented to the Commissioner, by the Kano State Essential Drug Officers Forum, for his examplary leadership in the health sector. Similarly, another one, an Award of Excellence in Supply Chain, was also presented to Pharm. Tukur Ibrahim, the immediate past Director Drugs and Supply at DMCSA, for his dedication and outstanding contributions to pharmaceutical services.
No comments:
Post a Comment